TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $15,000 | +200.0% | 194 | 0.0% | 0.00% | +100.0% |
Q1 2022 | $5,000 | -28.6% | 194 | +28.5% | 0.00% | 0.0% |
Q4 2021 | $7,000 | +40.0% | 151 | +93.6% | 0.00% | 0.0% |
Q3 2021 | $5,000 | +150.0% | 78 | +151.6% | 0.00% | – |
Q2 2021 | $2,000 | -50.0% | 31 | -24.4% | 0.00% | -100.0% |
Q1 2021 | $4,000 | – | 41 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |